Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 66

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 66
---
 unaudited condensed balance sheet of Cerevast as of September 30, 2024 on a pro forma basis as if the Business Combination and Other Related Events (in each case, as described further in the section entitled “ Unaudited Pro Forma Condensed Combined Financial Information” included elsewhere in this proxy statement/prospectus), had been consummated on September 30, 3024. The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2024 and the year ended December 31, 2023 combines the historical statements of operations of FutureTech, the historical statements of operations of Longevity, the historical statements of operations of Aegeria and the historical statements of operations of Cerevast on a pro forma basis as if each of the Business Combination, Other Related Events and Other Financing and Reorganization Events (in each case, as described further in the section entitled “ Unaudited Pro Forma Condensed Combined Financial Information” included elsewhere in this proxy statement/ prospectus) had been consummated on January 1, 2023, the beginning of the earliest period presented.

The unaudited pro forma combined financial information is based upon, and should be read together with the accompanying notes to the unaudited pro forma combined financial statements, the audited financial statements of FutureTech and related notes, the Longevity audited consolidated financial statements and related notes, the Aegeria audited financial statements and related notes and the Cerevast audited financial statements and related notes, the sections of this proxy statement/prospectus entitled “ FutureTechManagement’s Discussion and Analysis of Financial Condition and Results of Operations”, “Longevity Management’s Discussion and Analysis of Financial Condition and Results of Operations”, “Aegeria Management’s Discussion and Analysis of Financial Condition and Results of Operations”, “Cerevast Management’s Discussion and Analysis of Financial Condition and Results of Operations”, and other financial information included elsewhere in this proxy statement/ prospectus. The unaudited pro forma combined financial information has been presented for informational purposes only and is not necessarily indicative of what the combined company’s financial position or results of operations would have been had the Business Combination and related transactions been completed as of the dates indicated. In addition, the unaudited pro forma combined financial information does not purport to project the future financial position or operating results of the combined company following the consummation of the Business Combination. For more information, see the section entitled “ Unaudited Pro